UROXATRAL- alfuzosin hydrochloride tablet, extended release Stati Uniti - Ingliż - NLM (National Library of Medicine)

uroxatral- alfuzosin hydrochloride tablet, extended release

physicians total care, inc. - alfuzosin hydrochloride (unii: 75046a1xtn) (alfuzosin - unii:90347ytw5f) - alfuzosin hydrochloride 10 mg - uroxatral is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. uroxatral is not indicated for the treatment of hypertension. uroxatral is not indicated for use in the pediatric population. uroxatral is contraindicated for use: - in patients with moderate or severe hepatic impairment (childs-pugh categories b and c), since alfuzosin blood levels are increased in these patients [see use in specific populations (8.7) and clinical pharmacology (12.3)]. - with potent cyp3a4 inhibitors such as ketoconazole, itraconazole, and ritonavir, since alfuzosin blood levels are increased [see drug interactions (7.1) and clinical pharmacology (12.3)] . - in patients with known hypersensitivity, such as urticaria and angioedema, to alfuzosin hydrochloride or any component of uroxatral tablets [see adverse reactions (6.2)] pregnancy category b. uroxatral is not indicated for use in women, and there are no studies of alfuzosin in pregnant women alfuzosin was not teratogenic, embryotoxic or

ALFUZOSIN HYDROCHLORIDE tablet extended release Stati Uniti - Ingliż - NLM (National Library of Medicine)

alfuzosin hydrochloride tablet extended release

golden state medical supply, inc. - alfuzosin hydrochloride (unii: 75046a1xtn) (alfuzosin - unii:90347ytw5f) - alfuzosin hydrochloride 10 mg

ALFUZOSIN HYDROCHLORIDE ER tablet extended release Stati Uniti - Ingliż - NLM (National Library of Medicine)

alfuzosin hydrochloride er tablet extended release

avkare, inc. - alfuzosin hydrochloride (unii: 75046a1xtn) (alfuzosin - unii:90347ytw5f) - alfuzosin hydrochloride 10 mg

AURO-ALFUZOSIN TABLET (EXTENDED-RELEASE) Kanada - Ingliż - Health Canada

auro-alfuzosin tablet (extended-release)

auro pharma inc - alfuzosin hydrochloride - tablet (extended-release) - 10mg - alfuzosin hydrochloride 10mg - selective alfa-1-adrenergic blocking agents

ALFUZOSIN TABLET (EXTENDED-RELEASE) Kanada - Ingliż - Health Canada

alfuzosin tablet (extended-release)

sivem pharmaceuticals ulc - alfuzosin hydrochloride - tablet (extended-release) - 10mg - alfuzosin hydrochloride 10mg - selective alfa-1-adrenergic blocking agents

Alfuzosin 2.5mg tablets Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

alfuzosin 2.5mg tablets

a a h pharmaceuticals ltd - alfuzosin hydrochloride - oral tablet - 2.5mg

Alfuzosin 2.5mg tablets Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

alfuzosin 2.5mg tablets

sigma pharmaceuticals plc - alfuzosin hydrochloride - oral tablet - 2.5mg